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Abstract
Background: Fasciola spp. liver fluke cause pernicious disease in humans and animals. Whilst current control is
unsustainable due to anthelmintic resistance, gene silencing (RNA interference, RNAi) has the potential to contribute to
functional validation of new therapeutic targets. The susceptibility of juvenile Fasciola hepatica to double stranded (ds)RNA-
induced RNAi has been reported. To exploit this we probe RNAi dynamics, penetrance and persistence with the aim of
building a robust platform for reverse genetics in liver fluke. We describe development of standardised RNAi protocols for a
commercially-available liver fluke strain (the US Pacific North West Wild Strain), validated via robust transcriptional silencing
of seven virulence genes, with in-depth experimental optimisation of three: cathepsin L (FheCatL) and B (FheCatB) cysteine
proteases, and a s-class glutathione transferase (FhesGST).
Methodology/Principal Findings: Robust transcriptional silencing of targets in both F. hepatica and Fasciola gigantica
juveniles is achievable following exposure to long (200–320 nt) dsRNAs or 27 nt short interfering (si)RNAs. Although
juveniles are highly RNAi-susceptible, they display slower transcript and protein knockdown dynamics than those reported
previously. Knockdown was detectable following as little as 4h exposure to trigger (target-dependent) and in all cases
silencing persisted for $25 days following long dsRNA exposure. Combinatorial silencing of three targets by mixing
multiple long dsRNAs was similarly efficient. Despite profound transcriptional suppression, we found a significant time-lag
before the occurrence of protein suppression; FhesGST and FheCatL protein suppression were only detectable after 9 and
21 days, respectively.
Conclusions/Significance: In spite of marked variation in knockdown dynamics, we find that a transient exposure to long
dsRNA or siRNA triggers robust RNAi penetrance and persistence in liver fluke NEJs supporting the development of
multiple-throughput phenotypic screens for control target validation. RNAi persistence in fluke encourages in vivo studies
on gene function using worms exposed to RNAi-triggers prior to infection.
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Introduction
Fasciola spp. liver flukes are the causative agents of fascioliasis, or
liver fluke disease. Their growing importance as human neglected
tropical disease pathogens, alongside their impact on animal health,
welfare and global food security, is recognised [1–3]. This pathology
is compounded by established incidences of field resistance to the
handful of available flukicidal drugs in both veterinary and human
infections [4,5]. Although adult fluke are the reproductively active
stage and cause physical-, nutritional- and immuno-pathology to the
vertebrate host, it is the tissue-penetrating invasive newly-excysted
juvenile (NEJ)/juvenile stage Fasciola, that cause significant damage
to host tissues during their migration from the gut lumen, through
the hepatic parenchyma to the bile ducts. These NEJs are not
adequately targeted by existing chemotherapy; triclabendazole is
the only flukicide with significant activity against juvenile liver fluke
[6]. Novel flukicidal treatment options are urgently required,
especially those with activity against juvenile fluke.
Beyond two initial reports of RNA interference (RNAi) [7,8],
there have been no documented accounts of efforts to develop
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functional genomics tools for the study of liver fluke biology and
the validation of new drug and vaccine targets. Traditionally, such
studies were hindered by a relative lack of liver fluke nucleotide
sequence datasets compared to other parasitic helminths. Howev-
er, ongoing efforts have seen the primarily adult-derived sequence
datasets available through both GenBank and the Wellcome Trust
Sanger Institute complemented by the public release of tran-
scriptome datasets for adult specimens of both temperate and
tropical liver fluke (F. hepatica and F. gigantica respectively), soon
to be complemented by juvenile transcriptome datasets and draft
F. hepatica genome sequences [9–12]. A suite of functional
genomics tools and associated functional assays will be required in
order to effectively exploit these sequence resources.
RNAi permits the destruction of target mRNA, and subsequent
suppression of target protein, by the introduction of double
stranded (ds)RNA trigger molecules of complementary sequence to
an mRNA target [13]. In parasitic helminths and other species
that are difficult or impossible to transform by available molecular
genetic methods, RNAi provides a means of investigating gene
function through the relatively simple generation of organisms in
which the expression of a target gene has been reduced or ablated.
This approach permits both the testing of basic biological
hypotheses, and the identification of deleterious phenotypes that
might inform drug/vaccine target validation efforts. While
parasitic flatworms appear to be broadly amenable to RNAi
[14–16], the initial development of RNAi methodology in any
species requires optimisation of experimental variables, sometimes
on a target-by-target basis, validated by measurement of the extent
and specificity of transcript and protein knockdown [17].
Schistosoma mansoni has been well served by studies describing
extensive experimental optimisations of RNAi methodology [18–
22], enabling the effective exploitation of functional genomics tools
by the associated research community. RNAi can be induced in F.
hepatica by either soaking or electroporation [7,8]. Considering
the former method to be less onerous and less technically
demanding, and therefore more likely to be employed by the
research community in both small- and large-scale assay systems,
here we set out to apply dsRNA exposure-induced RNAi to silence
a range of virulence gene targets (and proposed vaccine antigen
candidates), including cathepsin B and L cysteine proteases, fatty-
acid binding protein, leucine aminopeptidase, and m-, v-, and s-
class glutathione transferases, in NEJs of a commonly-used,
commercially-available F. hepatica isolate (US Pacific North West
Wild Strain). Finding that RNAi transcript, protein and phenotype
dynamics were quite distinct in this system compared to those
reported previously in Oberon and Fairhurst isolates [8], we
performed a set of in-depth experimental optimisations in order to
characterise the RNAi mechanisms operating in this liver fluke
isolate. Focusing on three examples of commonly cited virulence
genes and vaccine targets – cathepsin B (FheCatB), cathepsin L
(FheCatL) and a sigma-class glutathione transferase (FhesGST),
we have systematically investigated the effects of variations in
dsRNA trigger concentration, experimental timecourse, and
dsRNA soak exposure protocol using both long (200–220 nt)
dsRNA and 27 nt short interfering (si)RNA triggers, on knock-
down of both target transcript and protein. We show that,
although apparently operating in a manner distinct to that
reported in existing literature [8], robust, persistent RNAi is
eminently achievable in NEJs of the F. hepatica Pacific North
West Wild strain, and in the tropical liver fluke F. gigantica, using
a simple dsRNA-exposure protocol.
Methods
Parasites
F. hepatica (US Pacific North West wild strain) metacercariae,
with outer cyst wall removed, were obtained from Baldwin Aquatics
Inc (Monmouth, Oregon, USA), and stored at 4uC until required.
F. gigantica metacercariae were obtained from naturally infected
wild snails collected in Aligarh, Uttar Pradesh, India, by researchers
at Aligarh Muslim University. Outer cyst walls were removed by
incubation in a solution of 1% pepsin, 4 mM HCl, for 90 min at
37uC, followed by several washes in distilled water. Metacercariae
were then excysted by incubation in 0.6% sodium bicarbonate,
0.45% sodium chloride, 0.4% sodium tauroglycocholate, 0.025 M
HCl, 0.4% L-Cysteine, for up to 3 h at 37uC. After approximately
75 min, at 10–15 min intervals, NEJs were transferred to RPMI
1640 without phenol red (Life Technologies), in which they were
maintained at 37uC for a maximum of 3 h until transferred to
soaking media. F. gigantica cysts were exposed to excystment media
for 3 h, after which they were transferred to RPMI for incubation,
in which their excystment completed within 18 h. Variations in
maintenance/soaking conditions are described below.
RNAi methodology
Experimental and negative control (dsCTRL) RNAi triggers
comprised ‘‘long’’ dsRNA molecules (sized between 200–320 nt)
generated by T7 polymerase-driven transcription of single RNA
strands (MEGAshortscript T7 Kit, Ambion) from target-specific
PCR product templates labelled either sense or antisense with a T7
RNA polymerase promoter sequence (59- TAATACGACTCAC-
TATAGGGT -39). Primers used to generate long dsRNA template
PCR products were: FheCatB2 [U58000]: forward, 59-
GTTGTCAGCCCTGGATGTTT -39, reverse, 59 -GTCC-
TGGAATATGGCGAAAG- 39; FheCatL [designed for maximum
similarity against alignment of all FheCatL clades on GenBank, see
Figure S1]: forward, 59-TKRTTATGTGACGGAGGTGA-39,
reverse, 59-GCCBKRTAHGGRTAAK-39; dsCTRL [bacterial
neomycin phosphotransferase, U55762]: forward, 59- GGTGGA-
GAGGCTATTCGGCTA -39, reverse, 59- CCTTCCCGC-
TTCAGTGACAA -39; FheFABP [AJ250098]: forward, 59-
TAAGATTACAACTTTCACATTTGGC -39, reverse, 59- GCG-
Author Summary
RNA interference (RNAi) is a method for selectively
silencing (or reducing expression of) mRNA transcripts,
an approach which can be used to interrogate the function
of genes and proteins, and enables the validation of
potential targets for anthelmintic drugs or vaccines, by
investigating the impact of silencing a particular gene on
parasite survival or behaviour. This study focuses on liver
fluke parasites, which cause serious disease in both
humans and animals. We have only a handful of drugs
with which to treat these infections, to which flukes are
developing resistance, and no anti-fluke vaccines have yet
been developed. New options for treatment and control of
liver fluke parasites are sorely needed, and RNAi is a
powerful tool in the development of such treatments. This
study developed a set of simple methods for triggering
RNAi in juvenile liver fluke, which show that although
robust transcriptional suppression can be readily achieved
across all targets tested, protein suppression occurs only
after a target-specific lag period (likely related to protein
half-life), which may require .25 days under current in
vitro maintenance conditions. These findings are important
for researchers aiming to employ RNAi in investigations of
liver fluke biology and target validation.
RNAi Dynamics in Juvenile Fasciola
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GGATGCTCAAAATCCGTC -39; FheLAP [AY644459]: for-
ward, 59- GGTAGTGAACTGTCAATTGTTCCG -39, reverse,
59- GAGTAGCAGATGTTTGCGTTGC -39; FhemGST [de-
signed against alignment of M77682, M93434, M77680,
M77681, M77679, see Figure S2]: forward, 59- ACACCCGAG-
GAACGAGCTCG -39, reverse, 59- TCGTAAACCATAAAGTC-
CACATGG -39; FhevGST [JX157880]: forward, 59- GATTGG-
TATCTGGAGTTATATCCG -39, reverse, 59- AATAAAAT-
ACCATGCGATTGAGCC -39; FhesGST [DQ974116]: forward,
59- AATTCGCCTTCTGCTCACTTGC -39, reverse, 59- GTAA-
TACTCTTCGTCTGTTTCACC -39). Endogenous templates
were amplified from F. hepatica (or F. gigantica) cDNA as
appropriate; due to high identity between the relevant orthologues,
we were able to use F. hepatica primers to amplify FgigsGST and
FgigGAPDH from F. gigantica (see ‘quantification of transcript
knockdown’ for GAPDH primer sequences). These amplicons were
sequence confirmed. Exogenous dsCTRL templates were amplified
from an eGFP plasmid (Promega). Complementary single-stranded
RNAs were combined and annealed (75uC for 5 min, 19uC for
30 min) before treatment with DNase (Turbo DNase, Life
Technologies) and RNase (RNase If, New England Biolabs) and
subsequent phenol/chloroform extraction and ethanol precipita-
tion. Pelleted dsRNA was briefly air-dried (,10 min) at room
temperature, resuspended in $100 ml DEPC-treated H2O, and
stored at 220uC. All dsRNAs were quantified using a NanoDrop
ND1000 Spectrophotometer and analysed for the presence of a
discrete, correctly sized product on a non-denaturing 1% (w/v)
agarose TAE gel. Only dsRNAs that gave a discrete correctly sized
band, and 260/280 and 260/230 ratios .1.8 were used in RNAi
experiments. Typical dsRNA concentrations following synthesis
were in excess of 2000 ng/ml. Verified sizes of dsRNAs were:
dsFheCatB: 248 nt; dsFheCatL 246 nt: nt; dsCTRL: 223 nt;
dsFABP: 313 nt; dsFheLAP: 234 nt; dsFhemGST: 218 nt;
dsFhevGST: 209 nt; dsFhesGST: 223 nt.
‘‘Dicer substrate’’ 27mer siRNAs to FhesGST were designed
and synthesised by Integrated DNA technologies (IDT; www.
idtdna.com) (target sites: siGST1: 59- TTCGAGGACTATCA-
ATTCACAATGGAT -39; siGST2: 59- GGGAAACTTAGACG-
TTATCAAGAATCG -39; siGST3: 59- ATTGCTCGATTG-
CTTGCCAGACAATTC -39; IDT’s off the shelf DS Scrambled
Neg siRNA (59- CTTCCTCTCTTTCTCTCCCTTGTGA -39)
was used as the siCTRL). Upon receipt, siRNAs were resuspended
in the supplied buffer to 100 mM concentration, and stored at 2
80uC in single-use aliquots until required.
NEJs were soaked in solutions of long dsRNA or siRNA dissolved
to defined concentrations in RPMI 1640, in 2 ml round-bottomed
microcentrifuge tubes. Soaks were handled at least in triplicate
alongside triplicate untreated (no dsRNA) and size- and concentra-
tion-matched negative control long dsRNA (dsCTRL)- or negative
control siRNA (siCTRL)-treated controls. For qPCR experiments
20 NEJs were used per soak, western blot experiments used 50 NEJs
per soak. Soaks were performed under one of five variations on a
dsRNA exposure protocol (described in Results – Burst exposure to
trigger). Unless specified otherwise, NEJs were maintained asepti-
cally in 1 ml RPMI 1640, at 37uC in a 5% CO2 atmosphere. RPMI
was replaced at 2–3 day intervals for periods of up to 25 days.
Worms were visually assessed for aberrant motility or morphology
during media changes. At the end of each soak experiment, worms
were either processed for RNA/protein extraction immediately, or
snap frozen and stored at 280uC for processing at a later time.
Quantification of transcript knockdown
mRNA was extracted from NEJs using the Dynabeads mRNA
Direct kit (Life Technologies). We employed the mini extraction
protocol as directed by the manufacturer (except that all washes were
performed with only 300 ml buffer), and eluted in 12.5 ml Tris-HCl.
Eluted mRNA was DNase digested using the Turbo DNA Free kit
(Life Technologies) in a total volume of 15 ml, from which 8 ml was
added directly to a 20 ml reverse transcription reaction using Applied
Biosystems’ High Capacity RNA to cDNA Kit, as described by the
manufacturer. Following reverse transcription, cDNA was diluted
with an equal volume of water before use in qPCR. Triplicate qPCR
reactions were performed in 10 ml reaction volumes using the
FastStart SYBR Green Master mix (Roche Applied Science),
containing primers (FheCatB: forward, 59-GCACGTACTGTGGT-
CAGGGGTG-39, reverse, 59-GTCCTGGAATATGGCGAAAG-
39; FheCatL: forward, 59-TKRTTATGTGACGGAGGTGA-39,
reverse, 59-GTATAGAAGCCAGTCACTTTGGC-39; FheFABP:
forward, 59- AACAAAATGACTATTAAAATGG -39, reverse, 59-
GCGGGATGCTCAAAATCCGTC -39, GAPDH reference am-
plicon [AY005475]: forward, 59- GGCTGTGGGCAAAGTCA-
TTC -39, reverse, 59- AGATCCACGACGGAAACATCA -39;
FheLAP: forward, 59- GGTAGTGAACTGTCAATTGTTCCG -
39, reverse, 59- GGCAGATAGAGTGCATGGTACG -39;
FhemGST: forward, 59- ACACCCGAGGAACGAGCTCG -39,
reverse, 59- GGATAAGCATGGAATGCTTGGT -39; FhevGST:
forward, 59- GATTGGTATCTGGAGTTATATCCG -39, reverse,
59- ATACGCAGACGCATTAGCTTCC -39; FhesGST: forward,
59- AATTCGCCTTCTGCTCACTTGC -39, reverse, 59- TC-
TTCACACTCACCAATGATACG -39) at final concentrations of
either 200 nM (FheCatB, FheCatL) or 1500 nM (FhesGST), as well
as 2 ml cDNA template (or H2O in the case of negative PCR
controls). As above, F. hepatica primers were used to amplify
FgigsGST and FgigGAPDH from F. gigantica. Amplification was
performed on a Qiagen RotorGene Q 5-plex HRM instrument
(10 min 95uC; 40 cycles: 10 sec, 95uC, 15 sec, 60uC, 30 sec, 72uC,
followed by melt curve analysis of amplicons). Relative expression
analysis was performed manually using Pfaffl’s Augmented DDCt
method [23] (which normalises expression in each sample relative to
the untreated control, standardised to a GAPDH reference
amplicon), with amplification efficiencies of individual reactions
calculated using Real Time PCR Miner software (http://ewindup.
info/miner/data_submit.htm; [24]). This analysis method produces a
ratio of target transcript change relative to the untreated control (i.e.
where a value of 1.0 represents no change)6 SEM. These ratios are
plotted in bar graphs in the qPCR figures. Statistical analyses were
performed on the ratios produced following relative expression
analysis, using one-way ANOVA with Tukey’s post test. Statistical
significance was determined relative to the effects of negative control
treatments (dsCTRL or siCTRL) on target gene expression.
Quantification of protein knockdown
Following soaking/maintenance using Protocol IV (as described
in Results – Burst exposure to trigger), 50 NEJs were ground under
liquid nitrogen in a round-bottom 2 ml microcentrifuge tube, after
which 50 ml radioimmunoprecipitation assay (RIPA) buffer,
containing protease inhibitors (Complete Mini, Roche Applied
Science) and phosphatase inhibitors (Phosphatase Inhibitor
Cocktail 2, Sigma Aldrich), was added. Tubes were then subjected
to 3620 sec cycles of sonication, and left on ice for 60 min before
quantification of protein content by BCA assay (BCA Protein
Assay Kit, Pierce). Following addition of 50 ml 26Novex Tricine
SDS Sample Buffer (Life Technologies), and tris(2-carboxyethyl)-
phosphine (TCEP) to a final concentration of 10 mM, samples
were denatured at 95uC for 5 min, and #25 ml of each sample
(equalised for protein content) loaded into wells of a pre-cast 10–
20%, 10 well, 1.0 mm, Tricine Gel (Life Technologies), alongside
one lane containing 15 ml SeeBlue Plus2 Prestained Standard (Life
RNAi Dynamics in Juvenile Fasciola
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Technologies). Gels were run in an Xcell Surelock Mini-Cell
apparatus (Life Technologies) at 135 V for 45–60 min in tricine
running buffer, before electroblotting onto nitrocellulose mem-
brane in an Xcell Mini-Cell apparatus (Life Technologies), at
35 V, for 2 h. Membranes were washed briefly with TBST (Tris-
Buffered Saline prepared from tablets [Sigma Aldrich], containing
0.05% Tween 20) before incubation in blocking buffer (TBST
containing 5% Blotting Grade Non-Fat Dry Milk [Biorad]), for
30 min, at room temperature, with rotation. Membranes were
then probed overnight at 4uC, with rotation, in blocking buffer
containing two primary antisera (one target and one loading
control normaliser) (rabbit-anti-sGST 1/15,000; rat-anti-Fhe-
CatB2 1/1000; sheep-anti-FheCatL1, 1/2000; rabbit-anti-actin
[20–33, Sigma Aldrich] 1/400). Following 565 min washes in
TBST, membranes were probed with appropriate secondary
antisera (alkaline-phosphatase conjugated goat-anti-rabbit (Invi-
trogen), goat-anti-rat (Invitrogen), or donkey-anti-sheep [Sigma
Aldrich], diluted 1/1000 in blocking buffer), for 2 h at room
temperature. Following 565 min washes in TBST, membranes
were exposed with NBT/BCIP solution (prepared from tablets,
Roche Applied Science). Development, carefully monitored by
eye, occurred in as little as 20 sec and was terminated by washing
the membrane thoroughly in distilled H2O. Membranes were then
dried, scanned, and band intensities quantified by densitometry
using ImageJ software (http://rsbweb.nih.gov/ij/). In order to
permit relative protein quantitation, band intensities for the
proteins of interest were normalised relative to the intensity of the
loading control band from the same sample, and then this figure
was expressed as a percentage relative to the untreated control
( = 100%) sample. Statistical analyses were performed using one
way ANOVA with Tukey’s post test. All statistical significances
presented in figures are expressed relative to the dsCTRL
treatment.
Accession numbers
The following accessions refer to GenBank (www.ncbi.nlm.nih.
gov). Bacterial neomycin phosphotransferase: U55762; cathepsin
B: U58000; cathepsin L: Z22767, EU287918, EU287915,
AJ279091, EU191984, AJ279093, EU287914, EU195859,
DQ534446, EU287917, EU287916, Z22763, DQ533985,
Z22764, EF407948, Z22765, EF611824, U62289, Z22769,
AJ279092, AY029229, AB009306, AY519972, AY573569,
L33771, AF490984, AY277628, U62288, AY519971,
DQ533986, Z22766, L33772, AF271385; fatty acid binding
protein: AJ250098; m-class glutathione transferase: M77682,
M93434, M77680, M77681, M77679; v-class glutathione trans-
ferase: JX157880; s-class glutathione transferase: DQ974116;
glyceraldehyde phosphate dehydrogenase: AY005475; leucine
aminopeptidase: AY644459.
Results
In vitro maintenance of NEJs
Although our early experiments were performed using Fasciola
saline (FS) maintenance media as described previously [8], we
found the viability (assessed as a visual measure of worm motility
and morphology; non-motile worms with a visually disrupted
tegument were considered dead) of NEJs to be poor over
maintenance periods of more than a few days under these
conditions (Figure 1). Initial soaks maintained 20 worms in 50 ml
FS, in which NEJs survived for no longer than 8 days (50%
survival = 5 days). With regular media changes (every 2 to 3 days),
maintenance could be extended to a maximum of 11 days (50%
survival = 9 days). Maintaining NEJs in a larger volume (1000 ml)
improved survival further to a maximum of 13 days (50%
survival = 12 days), although in this case NEJ survival was not
improved by regular media changes. In order to track protein
dynamics occurring on timescales beyond 13 days, we employed
RPMI 1640 media, finding that this media supported NEJ survival
for up to 27 days when maintained in aseptic conditions under a
5% CO2 atmosphere. All of the data presented below were derived
from experiments employing RPMI 1640, although comparative
experiments performed in both media across multiple targets over
72 h timescales illustrated no significant difference in RNAi
efficacy between FS and RPMI 1640.
RNAi transcript knockdown dynamics
This study aimed primarily to identify a set of optimised
RNAi experimental conditions that would permit simple and
robust gene knockdown in a widely used and commercially
available strain of F. hepatica. We describe a set of simple,
soaking-based methods that permit rapid, robust and persistent
knockdown of target transcripts, and address target-specific
aspects of the timecourse of this RNAi response, which is
particularly evident in the time lag between transcript and
protein knockdown.
Constant exposure to trigger
Initial experiments maintained NEJs under constant exposure
to long dsRNA for periods up to 72 h, using the same dsRNA
molecules/sequences, concentrations, and exposure conditions
previously reported [8]. These conditions did not, in our hands,
trigger aberrant motility phenotypes. Upon analysing transcrip-
tional knockdown dynamics from these soaks, we established
that there was no detectable difference in transcript knockdown
level between 50 ng/ml and 100 ng/ml dsRNA exposures. All
subsequent experiments employed 50 ng/ml dsRNA, unless
stated otherwise. Although we were unable to detect the
reduction in FheCatL transcript reported by McGonigle et al.
after 4 h exposure, simply extending the length of dsRNA
exposure did elicit time-dependent suppression of CatL, as well
as our other target transcripts after 72 h (FheFABP: 0.0360.01,
P,0.001, n= 3; FheLAP: 0.1660.10, P,0.01, n= 3; FhemGST:
0.0960.02, P,0.01, n= 3; FhevGST: 0.3860.06, P,0.05,
n= 3; Figure 2A). Note that these four targets were assayed only
by qPCR at the 72 h timepoint. Intermediate time-course
exposures, performed to 4, 24 and 72 h (Figure 2B–D), showed
that both FheCatL (24 h: 0.2960.20, P,0.05; n= 4; 72 h:
0.1660.06, P,0.01, n= 5), and FhesGST (24 h: 0.3860.05,
Figure 1. Survival of Fasciola hepatica newly excysted juveniles
(NEJs) in Fasciola saline (FS) vs RPMI 1640. NEJ viability in FS is
improved both by regular media changes (2change=without media
changes; +change=with media changes), or by maintenance in larger
volumes (50 ml vs 1000 ml). Experiments were replicated 3 times,
employing 15 worms per treatment. Symbols represent mean6SEM.
doi:10.1371/journal.pntd.0003185.g001
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P,0.05 n = 5; 72 h: 0.0260.004, P,0.01, n= 4) exhibited
significant transcript knockdown from 24 h onwards, while
FheCatB displayed a uniquely rapid response, with transcript
knockdown detectable after only 4 h exposure to long dsRNA
(4 h: 0.4060.16, P,0.05, n= 6; 24 h: 0.1360.06, P,0.05,
n= 4; 72 h: 0.0660.02, P,0.05, n= 4). None of these exper-
iments resulted in detectable aberrant phenotypes. The major
drawback of this approach was that NEJs maintained under
constant exposure to long dsRNA in such small volumes
exhibited rapidly declining viability beyond 2–3 days in vitro
(Figure 1), which occluded our detection of potential impacts of
RNAi on worm behaviour.
Burst exposure to long dsRNA trigger
Poor survival of NEJs under the constant exposure conditions
described above (here and in Figure 3 referred to as Protocol I)
was mitigated by either regular changes (every 2–3 days), and/or
maintenance in an increased volume (1 ml) of media. Since such
approaches would require prohibitively large amounts of RNAi
trigger during longer maintenance periods, we investigated the
Figure 2. Time-dependent transcript knockdown under constant exposure to long double-stranded (ds)RNA. A, knockdown of
virulence gene target transcripts after 72 h exposure to long dsRNA (CTRL, negative control; FABP, fatty acid binding protein; LAP, leucine
aminopeptidase; mGST, m-class glutathione transferase; vGST, v-class glutathione transferase; CatB, cathepsin B; CatL, cathepsin L; sGST, s class
glutathione transferase); B–D, time-dependent knockdown of cathepsin B (B), cathepsin L (C), s-class glutathione transferase (D). Square brackets e.g.
[CatB] represent qPCR amplicon. Target DDCt (Y-axes) represents ratio of abundance of target transcript to a reference gene (glyceraldehyde
phosphate dehydrogenase, GAPDH), in treated samples, relative to the abundance of those transcripts in untreated samples. Statistical significances
are indicated relative to effects of negative control dsRNA (dsCTRL, complementary to neomycin phosphotransferase). dsCTRL treatments were
performed in parallel with all experimental treatments. Experiments were repeated$4 times, employing 20–30 flukes per replicate. *, P,0.05; **, P,
0.01; ***, P,0.001. Symbols represent mean6SEM.
doi:10.1371/journal.pntd.0003185.g002
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efficacy of short, low volume ‘‘burst’’ exposures to long dsRNA,
followed by longer-term incubation in the absence of dsRNA
under optimal maintenance conditions. These experiments were
performed over a 72 h timecourse (Figure 3). Initial experiments
(Protocol II) incorporated a 4 h dsRNA burst exposure, after
which dsRNA was removed (or reduced to irrelevant levels) by a
series of six washes in 1 ml RPMI 1640, before maintenance for
68 h in 1 ml RPMI 1640. In all cases, target transcript
knockdowns had developed to highly significant levels by the
end of this maintenance period (FheCatB: 0.0960.02, P,0.001,
n=4; FheCatL: 0.1860.08, P,0.001, n=5; FhesGST:
0.1860.06, P,0.001, n=4; Figure 3B–D). Transcript knockdown
was triggered even when the burst exposure period was reduced to
as little as 30 min (Protocol III), although this knockdown was
statistically significant only in the cases of FheCatB and FhesGST
(FheCatB: 0.2360.11, P,0.01, n=3; FheCatL: 0.7960.08, P.
0.05, n=3; FhesGST, 0.2960.03, P,0.01, n=5). A 15 min
burst exposure was ineffective. Since NEJs were effectively
removed from dsRNA following the period of burst exposure
(and in the cases of FheCatL and FhesGST, knockdown had not
been present after 4 h, Figure 2C,D), these findings indicate that
dsRNA taken up by NEJs during their burst exposure period was
sufficient to trigger the development of knockdown during
subsequent incubation in the absence of exogenous dsRNA. In
two out of three cases, the highest levels of knockdown were
achieved over 72 h using the less onerous method (Protocol IV) of
simply adding 1 ml RPMI 1640 for 68 h after the 4 h soak period
(i.e. dilution of dsRNA to approximately 2.5 ng/ml) (FheCatB:
0.0260.003, P,0.001, n=3; FheCatL: 0.0160.0003, P,0.001,
n=5; FhesGST: 0.0860.01, P,0.001, n=7). To ascertain the
importance of the initial high-concentration burst exposure to this
response, we also performed soaks in the absence of this step
(Protocol V), simply soaking NEJs for 68 h in 2.5 ng/ml long
dsRNA. This approach also delivered highly significant levels of
transcript knockdown (FheCatB: 0.0160.003, P,0.001, n=6;
FheCatL: 0.0160.003, P,0.001, n=7; FhesGST: 0.1260.02,
P,0.01, n=3), indicating that the concentration threshold of the
NEJ long dsRNA uptake mechanism is#2.5 ng/ml. For reasons of
efficacy and convenience, all subsequent experiments in this study
employed Protocol IV.
RNAi in Fasciola gigantica
In order to establish the applicability of these RNAi methods to
the tropical fluke, F. gigantica, we applied long dsRNA
complementary to FgigsGST to F. gigantica NEJs using Protocol
IV methods. This triggered effective knockdown of FgigsGST
transcript (0.1960.03, P,0.001, n=5; Figure 3E). These data
represent the first demonstration of RNAi in F. gigantica. Note
that we did not examine suppression of FgigsGST protein, nor
any of the other genes referred to in this study, in F. gigantica.
Figure 3. Transcript knockdown following burst exposure to
long double-stranded (ds)RNA. Exposure conditions are indicated
in panel A, where newly-excysted juveniles were incubated in 50 ng/ml
dsRNA (black bar), 2.5 ng/ml dsRNA (grey bar) or zero/sub-effective
dsRNA (clear bar), for time periods as indicated in scale. Media were
replaced at 2–3 day intervals for the duration of the experiments.
Transcript knockdown was assayed in all cases by quantitative PCR,
72 h after start of soak. Target DDCt (Y-axes) represents ratio of
abundance of target transcript (B, cathepsin B; C, cathepsin L; D, sigma-
class glutathione transferase) to a reference gene (glyceraldehyde
phosphate dehydrogenase, GAPDH) in treated samples, relative to the
abundance of those transcripts in untreated samples. E, Silencing of
sGST ortholog in Fasciola gigantica, using long dsRNA exposure under
Protocol IV conditions. Data expressed as mean6SEM. Statistical
significances are indicated relative to effects of negative control dsRNA
(dsCTRL, complementary to neomycin phosphotransferase). dsCTRL
treatments were performed in parallel with all experimental treatments.
Experiments were repeated $3 times, employing 20–30 flukes per
replicate. *, P,0.05; **, P,0.01; ***, P,0.001. Symbols represent
mean6SEM.
doi:10.1371/journal.pntd.0003185.g003
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Persistent transcript knockdown leads to suppression of
target protein
Triggering highly significant levels of transcript knockdown over
the 72 h periods described above did not impact on the survival or
behaviour of NEJs maintained in vitro. Supporting this observa-
tion, western blot analyses of FheCatB, FheCatL and FhesGST
protein performed at 18 h and 72 h confirmed that target protein
levels had not changed significantly at these timepoints. Extension
of the in vitro maintenance period enabled detection of FhesGST
protein suppression after 9 days (61.7612.43%, p,0.05, n=4;
Figure 4A), which had increased further by 21 days
(24.6062.49%, P,0.001, n=3; Figure 4A). Suppression of
FheCatL protein was not detectable until 21 days (58.9766.74,
P,0.01, n=3; Figure 4B). FheCatB protein levels were not
reduced vs controls at all time points up to and including 21 days
(Figure 4C).
PCR analyses showed persistence of highly significant transcript
knockdown for all three targets throughout a 25 day period of
maintenance in vitro (day 25 FheCatB: 0.0360.01, P,0.001,
n=5; FheCatL: 0.1260.04, P,0.001, n=5; FhesGST:
0.0160.003, P,0.001, n=4; Figure 5), suggesting that inade-
quate target transcript knockdown is probably not responsible for
the absence of detectable FheCatB protein suppression at later
time points. Notably, even in experiments where suppression of
FheCatL or FhesGST protein was detectable, over maintenance
periods up to 25 days, we observed no changes in NEJ survival or
behaviour compared to time-matched negative controls.
Both long dsRNA and siRNA triggers are effective at low
ng/ml concentrations, and display concentration-
dependent impacts on target transcript abundance
All long dsRNAs tested triggered reproducible, concentration-
dependent knockdown of target transcripts. Although our standard
soak protocol employed 50 ng/ml long dsRNA, effective transcript
knockdown was also achievable using concentrations an order of
magnitude lower (5 ng/ml: FheCatB, 0.0960.01, P,0.01, n=3;
FheCatL, 0.4560.12, P,0.05, n=5; FhesGST, 0.2060.08, P,
0.01, n=4; Figure 6A–C). Statistically-significant transcript sup-
pression relative to control treatments was apparent with as little as
0.05 ng/ml long dsRNA in the case of FheCatB (0.3860.15, P,
0.05, n=3; Figure 6A). These observations are of practical
importance in permitting the possibility of combinatorial RNAi
(i.e. the silencing of multiple targets in parallel), an approach that
was demonstrated here by combining FheCatB, FheCatL and
FhesGST long dsRNAs to a final total concentration of 50 ng/ml
( = each individual dsRNA at 16.7 ng/ml). Under Protocol IV
conditions, this method triggered knockdown of all three targets in
parallel to a level not significantly different from that achieved in
Figure 4. Effects of RNA interference on target protein
abundance during maintenance in vitro. Densitometry analysis
performed of bands generated by immunoblot analyses of newly-
excysted juvenile (NEJ) crude protein extracts, at 9 and 21 days post
exposure to long double-stranded (ds)RNA: A, sGST; B, cathepsin L, C,
cathepsin B. Each panel includes typical examples of target bands
imaged from immunoblots using: (A) sigma glutathione transferase
antiserum (25 KDa), and actin antiserum (47 KDa) loading control; (B)
cathepsin L antiserum (preproenzyme, 37 KDa; partially-processed
intermediate, 30 KDa; mature enzyme, 24.5 KDa), and actin antiserum
(47 KDa) loading control; (C) anti-cathepsin B antiserum (preproenzyme,
36 KDa), and anti-FhesGST (sigma glutathione transferase, 25 KDa)
loading control. Bar graphs illustrate densitometric analyses of western
blot protein bands, where target band density is normalised to loading
control band density, and expressed relative to untreated sample
(where untreated control = 100%). Statistical significances are indicated
relative to effects of negative control dsRNA (dsCTRL, complementary
to neomycin phosphotransferase). Untreated and dsCTRL-treated
samples were performed in parallel with all experimental treatments;
these columns represent means of both time points. Experiments were
repeated $3 times, employing 50–60 flukes per replicate. *, P,0.05; **,
P,0.01; ***, P,0.001. Symbols represent mean6SEM.
doi:10.1371/journal.pntd.0003185.g004
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individual soaks (Figure 7A). No phenotypic impacts were
observed during the 72 h combinatorial RNAi timecourse,
although we did not investigate impacts on protein suppression
during these experiments.
In order to establish the efficacy of siRNAs in comparison to
long dsRNA, we employed three individual siRNAs complemen-
tary to FhesGST (siGST1–3). All three siRNAs triggered highly
significant knockdown of FhesGST transcript at 50 ng/ml
(siGST1: 0.0860.003, P,0.0001, n=3; siGST2: 0.1760.04,
P,0.001, n=3; siGST3: 0.1460.03, P,0.001, n=3; Figure 6D).
Titration of the most potent siRNA, siGST1, showed concentra-
tion-dependent effects that were significant at a concentration 10-
fold more potent than long dsRNA (siGST1 5 ng/ml: 0.3460.03,
P,0.01, n=5; 0.5 ng/ml: 0.4560.08, P,0.05, n=5; Figure 6D).
Long dsRNA transcript knockdown specificity
RNAi off-target impacts were assessed by amplifying non-target
amplicons from long dsRNA-treated cDNAs (Figure 7B). While
these analyses showed no evidence for off-target knockdown by
any of our long dsRNAs, we did observe some up-regulations of
transcripts following treatment with non-target long dsRNAs. This
phenomenon was only statistically-significant in the case of the
impact of FheCatL dsRNA on FheCatB. Further experimentation
is needed to fully characterise the consequences, and biological
significance, of such up-regulation on target protein levels.
Discussion
Development of RNAi-based gene silencing methods is pivotal
for the effective exploitation of burgeoning database resources for
parasitic helminths. Schistosoma spp. trematodes provide arguably
the best example of how the effective confluence of genomic
resources with powerful RNAi protocols can promote the systems-
level understanding of helminth parasite biology [25]. Fasciola
spp. liver fluke are increasingly the focus for genome and
transcriptome sequencing projects [9–12], but have not seen the
widespread adoption of RNAi and related tools by the liver fluke
research community. As a means of promoting such uptake, this
study aimed to develop a standardised set of RNAi protocols
applicable to NEJs of a widely used F. hepatica strain. We have
shown that transcriptional knockdown can be triggered in seven
virulence gene targets, simply by soaking NEJs in a solution of
tissue culture media containing long dsRNA, or siRNA, trigger
molecules. In three targets subject to in-depth optimisation of
variables, transcript knockdown occurred in a concentration-
dependent manner that was invariably rapid and persistent.
Although target-specific RNAi dynamics were apparent in terms
of the rapidity of transcriptional response to dsRNA trigger, these
dynamics manifested most notably in the length of the lag phase
between transcript knockdown and protein suppression. This lag
phase was appreciable in all cases, with FhesGST protein
suppression developing only 9 days following exposure to long
dsRNA, FheCatL suppression was not evident until 21 days post-
exposure. We were unable to detect FheCatB suppression at any
point up to and including 21 days. These manipulations did not
trigger any measurable changes in NEJ viability or behaviour in
vitro. Nevertheless, the protocols described here represent a
relatively simple means to achieve targeted transcript and protein
knockdowns in the absence of advanced manipulations such as
electroporation [7,26], biolistics [27], transfection reagents [28], or
genetic transformation [29], such as have been described in other
trematodes. Alongside development of appropriate functional
assays, these RNAi protocols should enable gene function analysis
even by laboratories with limited molecular expertise, and may
Figure 5. Persistence of transcript knockdown during mainte-
nance in vitro. Following exposure to target long double-stranded
(ds)RNA (A, cathepsin B; B, cathepsin L; C, sigma-class glutathione
transferase), newly-excysted juveniles (NEJs) were maintained in vitro
for up to 25 days. NEJs were collected and assayed by quantitative PCR
at 3, 9 and 25 days post dsRNA exposure. Target DDCt (Y-axes)
represents ratio of abundance of target transcript to a reference gene
(glyceraldehyde phosphate dehydrogenase, GAPDH), in treated sam-
ples, relative to the abundance of those transcripts in untreated
samples. Statistical significances are indicated relative to effects of
negative control dsRNA (dsCTRL, complementary to neomycin phos-
photransferase). dsCTRL treatments were performed in parallel with all
experimental treatments. Experiments were repeated $3 times,
employing 20–30 flukes per replicate. *, P,0.05; **, P,0.01; ***, P,
0.001. Symbols represent mean6SEM.
doi:10.1371/journal.pntd.0003185.g005
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lend themselves to multiple-throughput screening approaches to
target validation.
Despite the successful knockdowns reported here, our data
contrast with those of a previous study [8], which described
extremely rapid RNAi dynamics in F. hepatica NEJs of both
Oberon and Fairhurst isolates (see [30] for discussion of fluke
isolates). In the case of cathepsins B and L, McGonigle et al. [8]
demonstrated suppression of both target transcript and protein
after just 4 h exposure to long dsRNA, correlating at this time-
point with reduced migration through in an in-vitro rat gut
penetration assay. Although we attempted initially to replicate the
molecular aspects of those experiments using quantitative meth-
ods, we employed a commercially available and widely used strain
of F. hepatica, the US Pacific North-West Wild strain, instead of
Oberon and Fairhurst isolates. After 4 h exposure to long dsRNA,
we observed reliable knockdown only of FheCatB transcript
(Figure 2B). FheCatL remained refractory to transcript knock-
down after 4 h exposure, even over multiple replicates performed
over several days using independently prepared batches of long
dsRNA. Furthermore, throughout all of the experiments described
here, we never observed any of the ‘‘erratic locomotion and
paralysis’’ phenotypes reported by McGonigle et al. Even in soaks
employing 1 mg/ml FheCatL dsRNA (10 fold higher than that used
by McGonigle et al.), US Pacific North West strain NEJs displayed
Figure 6. Concentration-dependent effects of long double-stranded (ds)RNA and short interfering (si)RNA triggers on transcript
knockdown. Target long dsRNAs (A, cathepsin B; B, cathepsin L; C, sigma-class glutathione transferase), and sGST siRNAs (D) serially diluted in RPMI
1640, were applied to newly-excysted juveniles at the concentrations indicated. Transcript knockdown was assayed in all cases by quantitative PCR,
72 h after start of soak. Target DDCt (Y-axes) represents ratio of abundance of target transcript to a reference gene (glyceraldehyde phosphate
dehydrogenase, GAPDH), in treated samples, relative to the abundance of those transcripts in untreated samples. Statistical significances are
indicated relative to effects of negative control dsRNA (dsCTRL, complementary to neomycin phosphotransferase), or siRNA (siCTRL, commercially
supplied scrambled sequence). Control treatments were performed in parallel with all experimental treatments. dsCTRL and siCTRL bars illustrate the
impacts of the highest trigger concentrations tested (50 ng/ul). Experiments were repeated $3 times, employing 20–30 flukes per replicate. *, P,
0.05; **, P,0.01; ***, P,0.001. Symbols represent mean6SEM.
doi:10.1371/journal.pntd.0003185.g006
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no visibly different behaviour from controls, and no FheCatL
transcript knockdown, over a 4 h exposure period. After
addressing the relevant experimental variables between our
studies, the primary difference that remained was our use of
different F. hepatica isolates. Variable RNAi susceptibility has
been observed between strains of the nematode, Caenorhabditis
elegans [31], where inter-strain differences in somatic RNAi
competency correlate with differences in the capacity to mount an
anti-viral response. A similar situation could conceivably exist
between genetically-distinct liver fluke isolates, related to se-
quence-level differences in RNAi pathway proteins, although we
have been unable to test this hypothesis directly in F. hepatica
Oberon and Fairhurst isolates. However, planned draft genome
sequences from flukes of diverse genetic backgrounds, and
anthelmintic susceptibilities (Steve Paterson, Jane Hodgkinson,
personal communication) may shed further light on potential
isolate-related differences in RNAi mechanics. While strain/
isolate-specific RNAi susceptibilities could explain differences in
transcriptional responses to RNAi triggers as discussed here, based
on our current knowledge of RNAi mechanisms in other
organisms they do not adequately explain the differences in rates
of protein suppression observed between this work and that of
McGonigle et al. [8]. One may speculate that the proteins in
question may exhibit different half-lives in the distinct isolates used
in the respective studies, i.e. different post-RNAi protein
suppression rates could be due to longer target protein half-life
in the Pacific North West strain than in the Oberon/Fairhurst
isolates.
The transcript knockdown data described here clearly illustrate
that RNAi can be triggered using very simple methodology in
NEJs of the US Pacific North West Wild strain of F. hepatica.
Burst exposure experiments (Figure 3), and titrations of long
dsRNAs and siRNAs (Figure 6), show that even limited temporal
exposure to (30 min) or low concentrations (0.05 ng/ml) of long
dsRNA are sufficient to trigger the development of transcript
knockdown over a 72 h period. Transcript knockdowns also persist
at highly significant levels over maintenance periods of at least 25
days – this is reminiscent of S. mansoni, where cathepsin B
knockdown was reportedly sustained for at least 40 days following
delivery of long dsRNA by electroporation [19]. The transcrip-
tional acquiescence of NEJs to exogenously triggered RNAi
suggests the presence of a suite of efficient cellular RNAi
mechanisms, presumably involving a rapid and efficient dsRNA
uptake mechanism. This mechanism may involve SID (Systemic
RNAi Defective) homologues, dsRNA-gated channels responsible
for transmembrane-transport of dsRNA molecules, identified
originally in C. elegans [32–34] with orthologues described in S.
mansoni and several other disparate genera [35–41]. The
development of transcript knockdown over several days following
exposure to dsRNA suggests a slow intercellular spread of dsRNA
trigger from point of entry, and/or the presence of an RNA-
dependent RNA polymerase (RdRP)-like secondary siRNA-based
amplification system (although RdRPs have not yet been described
in flatworms, our unpublished bioinformatics analyses do suggest
the presence of RdRP-like sequences in available fluke datasets).
Throughout this study, no impacts were observed on NEJ
viability or behaviour during RNAi experiments. These observa-
tions were supported in early experiments by western blots
performed at 18 h and 72 h, which revealed no changes in levels
of FheCatB, FheCatL or FhesGST protein. Given that some
schistosome genes require maintenance periods of up to 14 days
post-electroporation before evidence of protein suppression or
phenotype [42], we hypothesised that protein suppression could be
similarly achieved in our targets simply by maintaining worms for
longer in vitro following dsRNA exposure, in order to permit run-
down of protein levels. Under such extended maintenance periods,
a western blot-based approach detected FhesGST suppression at
9 and 21 days post-exposure, while FheCatL suppression was not
detectable until 21 days post-exposure. No suppression of FheCatB
protein was detected at any point during the 21-day timecourse,
Figure 7. Combinatorial silencing and specificity of cathepsin
B, cathepsin L and sigma glutathione transferase RNAi on
target transcripts. (A) Newly-excysted juveniles exposed to a cocktail
of long double-stranded (ds)RNA against all three targets (individual
dsRNAs at 16.7 ng/ml concentration, final total dsRNA concentration,
50 ng/ml). (B) RNAi specificity, assayed via non-specific transcriptional
impacts of three target long dsRNAs. Target DDCt (Y-axes) represents
ratio of abundance of target transcript to a reference gene
(glyceraldehyde phosphate dehydrogenase, GAPDH), in treated sam-
ples, relative to the abundance of those transcripts in untreated
samples. Statistical significances are indicated relative to effects of
negative control dsRNA (dsCTRL, complementary to neomycin phos-
photransferase). dsCTRL treatments were performed in parallel with all
experimental treatments. Experiments were repeated 4 times, employ-
ing 20–30 flukes per replicate. *, P,0.05; **, P,0.01; ***, P,0.001.
Symbols represent mean6SEM.
doi:10.1371/journal.pntd.0003185.g007
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although an apparent upregulation of cathepsin B was detected in
our day 9 samples. Although we might assume that these
differential dynamics simply reflect the dissimilar run-down rates
of functionally distinct proteins, differences in the sequence
diversity of these targets might equally impact on our ability to
detect changes in protein abundance: FhesGST is a single copy
gene for which our long dsRNA had very little sequence identity to
other transcripts, and for which we had access to a specific
FhesGST-antiserum. In this case, detection of protein suppression
is a relatively simple matter, where changes in immunoblot band
density can be expected to provide an accurate read-out for
changes in protein abundance. In the case of multi-gene cathepsin
families, the ability to trigger and detect promiscuous changes in
protein abundance may depend on the relative specificity/cross-
reactivity of dsRNA and antisera, both within and between
members of the target gene family. In the case of cathepsin L,
where 78% mean sequence similarity exists between the seven
recognised F. hepatica cathepsin L clades, including many regions
of identity of .20 nt (consistent with generation of siRNAs by
Dicer), long dsRNA targeted to any clade is likely to trigger
promiscuous knockdown of the broader gene family. Polyclonal
antisera are likely to be similarly promiscuous across the multiple
cathepsin L protein clades, hence our detection of FheCatL
protein suppression by 21 days post dsRNA exposure. In the case
of cathepsin B however, sequence similarity across the ten
recognised clades is somewhat lower (mean 53%), and our long
dsRNA (in this study, complementary to FheCatB2) does not
possess significant stretches of identity with the other clades,
reducing the likelihood of promiscuous, broad knockdown of the
FheCatB gene family. In contrast, the cathepsin B polyclonal
antiserum used here is likely to cross-react with several cathepsin B
clades. Under these circumstances, suppression of FheCatB2 alone
may not have been detected by our immunoblot methodology
unless it accounted for the major proportion of expressed
cathepsin protein in the tissue extract (which is unlikely [43]).
This issue could be addressed quite simply in future studies by
employing a cocktail of dsRNAs representing all of the FheCatB
clades expressed in NEJs [44]. The combinatorial RNAi data
presented in Figure 7A, showed that at least three targets could be
silenced in parallel, supporting the feasibility of such an approach.
An alternative to the immunodetection approaches used here is
2D electrophoresis-based sub-proteomics, which has shown
promise in detecting RNAi-induced suppression of individual
proteins in multi-gene families in other systems (LaCourse et al.,
2008 [45]). Another technical consideration is that even where
FheCatL protein suppression was detected, our blots showed that
it was most apparent in the bands representing the 24.5 KDa
mature enzyme and 30 KDa processed intermediate, with little
reduction in band density apparent for the 37 KDa preproenzyme
(Figure 4). This phenomenon is likely due to the storage of
cathepsin L preproproteins as inactive zymogens within secretory
vesicles (a location likely to limit proteolytic breakdown), prior to
exocytotic release [43,46–49]). This may also have inhibited
detection of FheCatB protein suppression, since only the
preproprotein form was detected by our cathepsin B antiserum.
Alternatively, the apparently long protein half-lives seen here in
the face of transcript ablation may simply reflect our inability to
provide adequate maintenance conditions for obligate intra-
mammalian parasites, which has resulted in abnormal cell division
and cellular protein dynamics that artificially inhibit protein
turnover. Given the high and sustained levels of transcript
knockdown reported here, it seems unlikely that limiting transcript
knockdown is responsible for the apparent lack of protein
suppression in our experiments. Nevertheless, it is possible that
the delivery of dsRNA by other methods such as electroporation,
biolistics, transfection reagents, or genetic transformation
[18,19,27–29] may increase transcript knockdown levels, hasten-
ing the validity of phenotypic measurements. Varying the
mechanism of dsRNA delivery is a factor that could be addressed
by future experiments.
Despite detectable suppression of two out of three target
proteins, we observed no impact of RNAi on NEJ behaviour or
viability. Although these observations contrast with previous
reports of paralysis and compromised motility following RNAi of
cathepsin B and L in liver fluke [8], they are consistent with
silencing of these virulence genes in other organisms. Where RNAi
has been used to target cathepsin B, cathepsin L or GSTs in
multicellular eukaryotes in an in vitro setting, phenotypic
consequences have been reported only under functionally-defined
assay settings such as feeding/growth [26,29,50,51], drug suscep-
tibility [52,53], or in dynamic systems measuring reproductive
output or molting [54–57]. Under settings where organisms are
not subject to functional assay but merely observed in the presence
of RNAi (such as the present study), no impacts on survival or
motility have been reported following RNAi of cathepsin B,
cathepsin L, or GSTs [20,58–62]. The lack of impact on survival/
viability following RNAi in vitro is not necessarily a poor reflection
on the therapeutic potential of these targets, merely a confirmation
of the complexity and subtlety of the host-parasite interface that
highlights the need for adequately sensitive assay systems. In vivo
assays, where RNAi impacts on worm virulence are assessed via
the ability of an RNAi-treated parasite to develop to patency
within a host organism, have been employed in helminths
[25,54,63–66]. Although in vitro RNAi results cannot always be
recapitulated in vivo [64], the persistent knockdowns achieved in
the current study suggest the amenability of F. hepatica NEJ RNAi
studies to such an in-vivo infection assay. Efforts to develop in
vivo, and tailored in vitro assays for several targets are currently
ongoing in our laboratories. These assays will permit the
development of RNAi to its full potential in liver fluke.
This study has shown that RNAi protocols, based simply on
soaking in long dsRNA or siRNA even for brief periods, are
capable of triggering robust, persistent transcript knockdown in
liver fluke NEJs. However, notes of caution are offered in terms of
the possibility of liver fluke isolate-specific differences in RNAi
mechanics, and evidence for variable lag periods between
transcript and protein suppression; the latter highlight the need
for careful assessment of target dynamics prior to the application
and interpretation of phenotypic assays. The simple methods
described here should be widely applicable within the liver fluke
research community, and should bolster efforts both to investigate
liver fluke gene function and identify novel targets for therapy.
Supporting Information
Figure S1 PCR primer design strategy for induction and
detection of RNA interference (RNAi) in Fasciola hepat-
ica cathepsin L sequences. A, schematic layout of PCR
primers used for generation of double stranded (ds)RNA templates
labelled with T7 RNA polymerase promoter sequences, and a
quantitative (q)PCR amplicon. Note that both ‘sense’ and
‘antisense’ dsRNA templates are generated, from which sense
and antisense RNA strands are generated respectively, before
being annealed to generate dsRNA. B, nucleotide sequence
alignment of available Fasciola hepatica cathepsin L sequences,
showing positioning of primers and their cross-reactivity across
clades. Cathepsin L clades are indicated in sequence titles [CL1A,
1B, 2–6] as described elsewhere [67,68]. This alignment was
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performed in mid 2010, these sequences represent those available
in GenBank at that time, accession numbers refer to GenBank.
(DOCX)
Figure S2 PCR primer design strategy for induction and
detection of RNA interference (RNAi) in Fasciola hepat-
ica m-class glutathione transferase (GST) sequences. A,
schematic layout of PCR primers used for generation of double
stranded (ds)RNA templates labelled with T7 RNA polymerase
promoter sequences, and a quantitative (q)PCR amplicon. Note
that both ‘sense’ and ‘antisense’ dsRNA templates are generated,
from which sense and antisense RNA strands are generated
respectively, before being annealed to generate dsRNA. B,
nucleotide sequence alignment of available Fasciola hepatica m-
GST sequences, showing positioning of primers and their cross-
reactivity between sequences. GST titles and accession numbers
are indicated. This alignment was performed in mid 2010, these
sequences represent those available in GenBank at that time,
accession numbers refer to GenBank.
(DOCX)
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